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Optical imaging of whole, living animals has proven to be a powerful tool in multiple areas of preclinical research and has
allowed noninvasive monitoring of immune responses, tumor and pathogen growth, and treatment responses in
longitudinal studies. However, fluorescence-based studies in animals are challenging because tissue absorbs and
autofluoresces strongly in the visible light spectrum. These optical properties drive development and use of fluorescent
labels that absorb and emit at longer wavelengths. Here, we present a far-red absorbing fluoromodule–based
reporter/probe system and show that this system can be used for imaging in living mice. The probe we developed is a
fluorogenic dye called SC1 that is dark in solution but highly fluorescent when bound to its cognate reporter, Mars1. The
reporter/probe complex, or fluoromodule, produced peak emission near 730 nm. Mars1 was able to bind a variety of
structurally similar probes that differ in color and membrane permeability. We demonstrated that a tool kit of multiple
probes can be used to label extracellular and intracellular reporter–tagged receptor pools with 2 colors. Imaging studies
may benefit from this far-red excited reporter/probe system, which features tight coupling between probe fluorescence and
reporter binding and offers the option of using an expandable family of fluorogenic probes with a single reporter gene.
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Introduction
Imaging of live animal models has advanced the development and 
refinement of many oncologic therapies by allowing investigators 
to specifically and noninvasively monitor clinically relevant param-
eters such as tumor size and rate of growth, degree of vasculariza-
tion, immune infiltrates, and responses to therapeutic agents over 
time (1–3). The ability of in vivo imaging to provide informative 
data relies upon the ability to tag specific targets of interest with 
labels that generate signals detectable through tissue. Targeted 
labeling can be achieved by using reporter/probe systems, a num-
ber of which are presently used in different imaging modalities. 
Human herpes simplex virus type 1 thymidine kinase/[18F]FHBG 
and sodium iodide symporter/124I reporter/probe pairs are exam-
ples of existing methods of selectively accumulating radionuclides 
in transgene-expressing cells for PET imaging (4–7). Reporter/
probe systems are also utilized for optical imaging modalities to 
target bioluminescent and fluorescent signals. However, most 
probes generate signals regardless of whether they have local-
ized to their target. Signals from circulating probe can undesirably 
degrade contrast between the target and its surroundings. A pow-
erful strategy for minimizing this source of background is to use 
activatable probes that produce signals only in response to specific 
cues such as low pH (8, 9), endogenous enzyme activity (10, 11), 
or interaction with reporter gene products. Luciferins, for example, 
generate light only after luciferase-mediated oxidation, provid-
ing exceptional contrast between reporter activity and circulating 
probe (12). Fluorogenic SNAP-tag substrates provide similar func-
tions for fluorescence imaging, but most of these absorb and fluo-
resce at wavelengths nonideal for tissue imaging (13–16).
While fluorescence imaging is a staple resource for addressing 
biological and pharmacological questions in vitro and in cultured 
cell systems, its potential in animal studies remains underex-
ploited because many existing fluorescent tools are incompatible 
with the optical properties of tissue. Tissues present overwhelm-
ing absorbance, scattering, and autofluorescence, which con-
found and degrade the quality of data obtained from labels that 
absorb and emit light in the visible spectrum (17–19). Tissues are 
more transparent to longer wavelengths of light (700–1000 nm), 
and this spectral window allows excitation and detection of even 
deeply embedded optical probes. Ideal reporter/probe systems 
for in vivo optical imaging should absorb and emit maximally 
within this window, generate signals specifically from the target, 
and produce bright signals to minimize detection thresholds and 
image acquisition times.
Fluoromodules are a class of reporter/probe systems that 
feature robustly activatable probes that could be optimized, with 
respect to wavelength, for in vivo imaging. A fluorogenic synthetic 
dye (a fluorogen) serves as the probe, and a cognate scFv-based 
fluorogen activating protein (FAP) functions as a reporter. Each 
component alone is dark. When combined, probe and reporter 
form a highly fluorescent complex that is similar in molecular 
weight (24.4 kDa) to monomeric fluorescent proteins such as GFP 
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face-displayed receptors. The sulfonate group has previously been 
shown to impart polarity and consequently inhibit dye movement 
across lipid bilayers when attached to fluorescent dyes and other 
fluorogens (22, 31, 32).
Selection of Mars1 and Mars1Cy. Mars1 was developed from a 
previously reported scFv, designated HL9-MG, which was one of 
the first FAPs isolated from a naive scFv library for its ability to acti-
vate fluorescence in MG-based fluorogens (20). The light chain of 
HL9-MG was previously found sufficient for fluorogen activation 
(33). Studies of similar light chain–only FAPs have shown that the 
assembled fluoromodule contains 1 fluorogen molecule bound 
between 2 light chains and that tethering of 2 light chains by a flex-
ible linker increases binding affinity (28, 34). A gene encoding a 
peptide-linked dimer of light chains from HL9-MG was generat-
ed, randomly mutagenized, and screened using a yeast expression 
system and cell sorting in hopes of finding clones with improved 
binding and fluorescence activation of a membrane-permeant 
MG derivative, MG-ester. One mutant recovered from screening, 
designated Mars1, was found to exhibit increased expression and 
activity and, upon sequencing, was found to host a V70A muta-
tion in the N-terminal light chain. This clone was also identified as 
activating fluorescence from SC1.
Seeking to further improve the expression characteristics of 
Mars1 and simultaneously explore the possibility of adjusting its 
affinity toward SC1, we propagated the V70A mutation to both 
light chains of Mars1 to generate a symmetric template. This tem-
plate was subjected again to PCR-mediated random mutagenesis 
in order to produce a library suitable for SC1-activation screening. 
This process led to isolation of Mars1Cy, a mutant that hosts Y96H 
mutations on both light chains in addition to both V70A muta-
tions present in its parent. Expression of Mars1 and Mars1Cy from 
otherwise identical vectors in the cytoplasm of mammalian cells 
indicated that the latter clone presents more robust activity in this 
environment (Supplemental Figure 1).
Characterization of fluoromodule properties. The spectral and 
binding properties of Mars1 and Mars1Cy with SC1 and SCi1 were 
studied in vitro using purified protein recovered from either yeast 
(Saccharomyces cerevisiae) or bacterial (E. coli) expression systems. 
The Mars1:SC1 fluoromodule absorbs light in the far-red spectrum 
(Figure 1B), possesses a dissociation constant of 7.9 nM, and produc-
es fluorescence with peak excitation and emission wavelengths of 
702 and 731 nm, respectively. The excitation spectrum is broad and 
includes a secondary peak at 615 nm (Figure 1C). The other 3 fluo-
romodules are highly similar both in spectral properties (Figure 1C) 
and binding affinities (Table 1). Mars1Cy binds slightly less tightly to 
both fluorogens when examined in vitro. Critically, the fluorogens 
SC1 and SCi1 exhibit negligible fluorescence in the absence of cog-
nate FAP, both in aqueous buffer and in whole serum (Figure 1C). 
Fluorescence enhancements of 3,300- (n = 16, SD = 650) and 2,000-
fold (n = 16, SD = 210) for SC1 and SCi1, respectively, were obtained 
by comparing free versus Mars1Cy-bound fluorogen in PBS. Mars1 
produced similar enhancements: 3,200- (n = 16, SD = 620), 2,100-
fold (n = 16, SD = 220). Binding occurred rapidly upon addition of 
fluorogen to cognate FAP (Figure 1D). These FAPs also retained the 
ability to bind and induced shorter wavelength fluorescence from 
MG-based fluorogens (Supplemental Figure 2) that have been well 
characterized with use in different fluoromodules (20, 35).
(20). This fluorescence activation is thought to arise when dyes are 
prevented from twisting into nonradiative excited state conforma-
tions upon binding to FAPs, increasing fluorescence intensity by 
up to 18,000-fold (20, 21). Fluoromodules are versatile, since an 
FAP can bind and activate a host of structurally similar but func-
tionally distinct probes. This property has been exploited to cre-
ate membrane-permeant and -impermeant fluorogens, amplify 
fluoromodule brightness, and build activatable pH-reporting 
ratiometric probes that can all be activated by the same FAP (20, 
22–24). All previously described fluoromodules, with one excep-
tion (K7:TO-PRO-5), absorb and fluoresce maximally in the vis-
ible light spectrum, which limits their effectiveness for animal 
imaging experiments (20, 25–28).
Here we describe a fluoromodule-based reporter/probe sys-
tem that absorbs and emits at wavelengths well suited for in vivo 
imaging. The reporter FAP, Mars1, possesses nanomolar affinity 
for a far-red absorbing probe: a fluorogen called SC1. Like other 
fluorogens, SC1 is an activatable probe: negligibly fluorescent 
in solution, but intensely fluorescent, with excitation and emis-
sion maxima at 701 and 731 nm, respectively, upon binding to 
its cognate FAP. The corresponding fluoromodule, Mars1:SC1, 
assembles rapidly, and its fluorescence is stable across a broad 
pH range. We also discuss Mars1Cy, a mutant of Mars1 with 
improved expression in mammalian cells, and the design of SCi1, 
a membrane-impermeant version of SC1 for labeling cell-surface 
proteins. Both reporters can be used to tag a variety of intracel-
lular and cell-surface proteins. They can also bind and activate 
malachite green–based (MG-based) fluorogens that absorb and 
fluoresce at different wavelengths, which enables 2-color labeling 
of intracellular and extracellular protein populations. Cells that 
express Mars1Cy:SC1 can be imaged through the skin of mice, and 
fluorogens can be delivered to FAP-bearing tumors via i.p. and i.v. 
injection. Imaging with this reporter/probe system is feasible in a 
small animal model, even when restricted to nonoptimal excita-
tion and emission channels. The tissue-compatible excitation and 
emission wavelengths, activatable nature of fluorogens, and abil-
ity to selectively label extracellular proteins may be advantageous 
for many animal imaging investigations.
Results
Fluorogen design. SC1 (Figure 1A) was designed to structurally mim-
ic MG while incorporating lengthened charge delocalization, since 
studies of cyanine dyes show that extended charge delocalization 
corresponds to increased absorption wavelengths (29). From its 
similarity to triarylmethane dyes and MG-based fluorogens, we 
predicted that SC1 would be nonfluorescent in water, but would 
become fluorescent if bound and rigidized by a compatible FAP. 
SC1 was expected to be membrane permeant and therefore use-
ful for labeling intracellular FAP-tagged targets due to its compo-
sitional and structural similarity to MG (30). Mars1 and Mars1Cy 
bind and activate fluorescence from MG-based fluorogens such as 
MG-ester and MG-2p, in addition to SC1, indicating that variation 
in probe structure, particularly in the form of flexible linkers on 
the end distal to the diarylmethane group, is tolerated. We there-
fore attached a short linker and sulfonate group to SC1 to create a 
membrane-impermeant fluorogen, SCi1 (Figure 1A), intended for 
selective labeling of extracellular FAP-tagged targets such as sur-
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a 731/137 nm emission filter under 640 nm excitation (Figure 
2, A and B). The observed fluoromodule brightness exhibited a 
dependence on expression context: the C-terminal eGFP fusion 
construct yielded approximately 2-fold greater mean brightness 
over nonfused Mars1Cy.
Use of Mars1 and Mars1Cy as fusion tags in various cellular con-
texts. The utility of Mars1 and Mars1Cy fluoromodules to act as 
fluorescent tags in living cells was further explored by expressing 
the FAPs in a variety of cellular environments, either by append-
ing a signal sequence that directs a specific subcellular localization 
or by fusing the FAP to a native protein. Targeting of Mars1 to the 
plasma membrane and Mars1Cy to the mitochondrial matrix by 
utilizing Igκ- and COXIV-1–derived signal peptides, respectively, 
was demonstrated in HEK293 cells (Figure 2, C and D). Mars1Cy–
β-actin, Mars1Cy-vimentin, histone H1.1–Mars1Cy, and Mars1Cy-
IGF1R fusion proteins were expressed in HeLa cells (Figure 2, 
E–H). In these examples, cells expressing CMV-driven FAP con-
structs were used to establish stably expressing clonal lines that 
were maintained for weeks in the absence of chemical selection.
The feasibility of long-term labeling of living cells was also 
explored. An HEK293 strain expressing cytosolic Mars1Cy-eGFP 
was cultured continuously in media supplemented with 200 nM 
SC1 over a 52-day period, during which the proportion of FAP-
expressing cells was periodically monitored by flow cytometry 
and observed to remain stable. The population positive for fluo-
rescence in both channels exhibited little fluctuation over 10 mea-
surements, with a mean value of 98% positive for both eGFP and 
FAP fluorescence (SD, 0.39%).
Two-color labeling of extracellular and intracellular protein 
populations. We tested the use of fluorogens that excite and emit 
at different colors as a means of differentiating between external 
and internal populations of Mars1Cy-labeled arginine vasopres-
sin receptor 2 (AVPR2, Homo sapiens) in cultured cells. A CMV 
promoter–driven gene encoding Mars1Cy-AVPR2 was introduced 
into HEK293 cells via lentiviral transduction in order to obtain a 
stably expressing clonal cell line that expresses FAP-tagged AVPR2. 
A membrane-impermeant fluorogen such as MG-2p or SCi1 was 
used to saturate FAP-tagged receptors on the exterior of the cell. 
We found that receptors labeled in this manner remained respon-
sive to stimulation by desmopressin (Figure 3A). Initial labeling 
of cells with membrane-impermeant fluorogen for a brief period 
(10 minutes), followed by addition of a differently colored mem-
brane-permeant fluorogen such as MG-ester or SC1 to SCi1- or 
MG-2p–labeled cells, respectively, allowed specific labeling of the 
intracellular protein pool by the membrane-permeant fluorogen. 
The fluorogens SC1 and SCi1 had extinction coefficients 
of 120,000 and 97,000 M-1cm-1, respectively, when dissolved 
in methanol with 5% (v/v) glacial acetic acid, with absorbance 
maxima at 691 and 696 nm. The spectral properties of these 
fluorogens bound to Mars1 and Mars1Cy in PBS at pH 7.4 are 
summarized in Table 1.
A limitation exhibited by many fluorescent protein reporters 
is the dependence of fluorescence intensity upon environmental 
factors such as pH, a characteristic that can confound quantitative 
measurements. The stability of Mars1 and Mars1Cy across a broad 
range of pH values was investigated by incubating the respective 
SC1 and SCi1 fluoromodules in a Carmody buffer series spanning 
2.0 to 10.0 (36). Fluorescence intensities at 730 nm remained 
broadly stable, only showing substantial signal loss above pH 9.0 
(Figure 1E). No pH dependence in signal intensity was observed 
even after incubation at room temperature for 30 hours.
Membrane permeability of SC1 and SCi1. We expressed Mars1 
and Mars1Cy in the cytoplasm of mammalian cells to confirm that 
they remain active in the intracellular environment. The resulting 
cell strains provided an opportunity to verify the predicted abili-
ties of SC1 and SCi1 to cross cell membranes. We reasoned that a 
membrane-permeant fluorogen would gain entry to these cells 
and become fluorescent upon binding intracellular FAP, while 
membrane-impermeant fluorogens would be excluded from cells, 
which would consequently remain dark. HEK293 cells expressing 
cytosolic Mars1Cy-eGFP (where eGFP indicates enhanced GFP) 
were therefore incubated with either SC1 or SCi1. Fluoromodule 
and eGFP emissions were recorded by flow cytometry prior to and 
at intervals after the application of fluorogen (200 nM) to cell sus-
pensions maintained at 37°C. Addition of SC1 produced an approxi-
mately 10,000-fold increase in fluorescence, relative to pretreat-
ment and nontransfected cells, after 10 minutes. SCi1 produced a 
2-fold signal increase within the same interval (Figure 1F). Similar 
trends in signal intensity change over time were observed from cells 
incubated at 20°C and on ice (Supplemental Figure 3, A and B).
Comparison of brightness between Mars1Cy and IFP1.4 in living 
cells. HEK293 cells expressing cytosolic Mars1Cy and IFP1.4 with 
eGFP in the form of a fusion protein or as separate polypeptides 
expressed at stoichiometric levels via a P2A sequence (37) were 
used to compare the in vivo brightness of Mars1Cy:SC1 with that 
of IFP1.4 via microscopy. IFP1.4-expressing cells grown in media 
supplemented with 50 μM biliverdin-IX for 48 hours prior to 
imaging were 6- to 16-fold dimmer than cells expressing an equal 
amount of Mars1Cy labeled with 400 nM SC1 (normalization 
was carried out using coexpressed eGFP), as observed through 
Table 1. Physical and spectral properties of Mars1 and Mars1Cy complexed with SC1 and SCi1
Name KD (nM) Mass (kDa) Ex/Em. max ε (λmax) φr % BR
Mars1:SC1 7.9 24.4 702/731 nm 1.2 × 105 17 20
Mars1:SCi1 2.6 24.4 703/733 nm 9.0 × 104 21 19
Mars1Cy:SC1 12.2 24.4 702/731 nm 1.2 × 105 17 20
Mars1Cy:SCi1 7.6 24.4 703/733 nm 9.8 × 104 23 23
Molecular brightness (BR) is here calculated as the product of the extinction coefficient at the wavelength of maximum excitation, and the fluorescence 
quantum yield φ in mM–1cm–1 (54). Ex/Em. max, wavelengths that correspond to fluorescence excitation and emission maxima, respectively. 
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performance in various in vivo imaging scenarios. HCT116 cells 
were transduced with lentivirus to afford expression of either 
iRFP713-eGFP or Mars1Cy-eGFP in the cytoplasm. A simi-
lar vector bearing an Igκ signal sequence and transmembrane 
anchor was used to express Mars1Cy on the plasma membrane 
surface. Single cell–derived populations expressing each pro-
tein were isolated, and protein expression was verified by flow 
cytometry (Supplemental Figure 5). To gauge the performance 
of our fluoromodules relative to iRFP713 within the context of 
living animals, we performed s.c. injection of defined num-
bers of cells into the flanks of athymic nude mice. Transduced 
cells hosting either protein were visible through the skin and 
easily distinguished from tissue autofluorescence in all cases, 
down to the minimum injected dose of 300 cells (Figure 4A). 
We found that the fluorescent protein and fluoromodule yield-
ed comparable signals for all amounts of injected cells (Figure 
4B and Supplemental Figure 6), though the 680 channel of the 
FMT2500LX instrument more effectively excited and collected 
light from iRFP713 than Mars1Cy.
Feasibility of systemic fluorogen delivery to tumors. Recog-
nizing that ex vivo labeling of samples is impractical for many 
Mars1Cy:MG-2p and Mars1Cy:SCi1 fluoromodules produce easily 
separable colors, and we observed that addition of SCi1 followed 
by MG-ester or addition of MG-2p followed by SC1 allowed 2-color 
labeling of extracellular versus intracellular protein prior to and 
during desmopressin-stimulated endocytosis (Figure 3B).
Imaging of FAPs in the presence of nonbinding dyes. Various red 
to near-infrared fluorophores, TMR isothiocyanate (TRITC), Lis-
samine Green B, Oxazine 1, methylene blue, Cy5.18, and Cy7, were 
incubated with Mars1-expressing cells, which were imaged to exam-
ine whether Mars1 can bind different dyes. Binding was expected 
to produce signal enrichment at the plasma membrane (for non-
membrane permeant dyes) or in the secretory pathway as well as the 
plasma membrane in the case of membrane-permeant dyes. SCi1 
was then added to the samples, which were imaged again to assess 
whether the presence of other dyes prevents fluorogen binding and 
activation. None of the dyes tested appeared to bind to Mars1, in that 
they failed to enrich signals at sites of FAP expression, nor did they 
prevent binding and activation of SCi1 (Supplemental Figure 4).
Imaging of fluoromodules in a small animal model. The optical 
properties of these fluoromodules make them excellent candi-
dates for animal imaging–based studies, so we examined their 
Figure 1. Properties of Mars1- and Mars1Cy-based fluoromodules. (A) Chemical structures of fluorogens SC1 (membrane permeant) and SCi1 (membrane 
impermeant). (B) Absorbance spectra: SC1 in acidic (5% glacial acetic acid) methanol (mean, 4 samples) and Mars1:SC1 in PBS, pH 7.4 (mean, 2 samples); spectra 
are scaled to have peak absorbance of 1.0 units. Free and bound forms of SCi1 are similar but with a 3 nm bathochromic shift. (C) Excitation (dashes, mean of 
5 samples) and emission (solid, mean of 4 samples) spectra of SCi1 in PBS and FBS with and without Mars1Cy; spectra of Mars1 and SC1 are virtually identi-
cal. Intensities are expressed as a fraction of the maximum signal. (D) Binding and fluorescence activation traces of Mars1:SC1, Mars1:SCi1, Mars1Cy:SC1, and 
Mars1Cy:SCi1 (1 acquisition per fluoromodule) recorded from solutions where [FAP] = KD and [fluorogen] = 10 KD. Respective on rates (3.3 × 10
6, 2.8 × 106, 3.7 × 105, 
and 1.5 × 106 M-1s-1) were calculated from activation observed at 4 different concentrations of fluorogen. (E) Fluorescence of Mars1 fluoromodules in buffers span-
ning pH 2.0 to 10.0 measured 1 and 30 hours after sample preparation. Points indicate mean sample fluorescence (n = 5: Mars1:SC1/1 hour, n = 4: others). Bars 
indicate SD. Values are scaled such that the highest mean signal is 1.0. Mars1Cy exhibits similar pH insensitivity. (F) Fluorescence from HEK293 cells that express 
cytoplasmic Mars1Cy-eGFP, and untransfected control cells maintained at 37°C prior to (0 minutes) and at intervals after addition of SC1 or SCi1. Points denote 
average of median population intensities (n = 3 separate samples prepared identically) analyzed by flow cytometry.
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Discussion
In this work, we present an activatable fluorescent reporter/
probe system with properties suited for whole animal imaging. 
These fluoromodules, composed of Mars1 and Mars1Cy FAPs 
paired with SC1 and SCi1 fluorogens, maximally absorb and 
emit near 700 and 730 nm respectively, where tissue absor-
bance and autofluorescence subside, and provide stable fluo-
rescence intensity across a broad range of pH conditions. The 
fluorescence quantum yields measured for Mars1 and Mars1Cy 
bound to SC1 and SCi1 are several-fold greater than report-
ed values for spectrally similar fluorescent reporter proteins 
(38–41), and we observed that Mars1Cy appears substantially 
brighter when imaged alongside IFP1.4 in cultured cells. We 
have shown here that the far-red absorbing dyes SC1 and SCi1 
are fluorogenic: dark in solutions such as PBS and FBS as well 
as suspensions of cultured mammalian cells and highly fluores-
cent upon binding to Mars1 or Mars1Cy. The thousands-fold dif-
ference in fluorescence between bound and unbound fluorogen 
allows FAP-tagged proteins, expressed in cultured cells, to be 
imaged without washing away excess fluorogen. This property 
could also be advantageous for in vivo imaging in mice because 
it reduces signals contributed by probes in circulation.
animal imaging experiments, we next inquired whether these 
fluorogens can be delivered to FAP-hosting cells in living mice 
via injection into the i.p. cavity or administration via tail vein. In 
one experiment, HCT116 cells that express plasma membrane–
directed Mars1Cy were used to form tumors in mice. Membrane-
permeant fluorogen was then delivered via i.p. injection, after 
which the host animal was sacrificed and the tumor extracted 
and sectioned. Fluorescence from SC1 bound to Mars1Cy was 
detected within the tumor sections via confocal microscopy (Fig-
ure 4C), even near the center of the tumor. We further imaged 
s.c. tumors generated using the same cell line and found that 
labeling can be obtained from administration of membrane-
permeant fluorogen via i.p. and i.v. routes (Figure 4, D and E, 
respectively) and impermeant fluorogen via i.p. and i.v. routes 
(Figure 4, F and G, respectively). Finally, to determine whether 
these fluoromodules allow visualization of targets deeper within 
a host animal, we generated FAP-bearing tumors in the i.p. cavity 
of mice. Once tumors reached 10 to 25 mm3, SC1 and SCi1 were 
delivered via i.p. injection, and fluorescence was quantified (Fig-
ure 4, H–J). Labeled tumors were also extracted, sectioned, and 
imaged to assess the degree of labeling throughout the cell mass 
with different fluorogens (Supplemental Figure 7).
Figure 2. Fluoromodules appear brighter than 
IFP1.4 and are functional when expressed within 
mammalian cells. Channels are labeled DIC or 
formatted excitation:emission/bandwidth. (A) 
HEK293 cells expressing Mars1Cy-eGFP or IFP1.4-
eGFP fusion proteins, from otherwise identical 
vectors, were imaged in the presence of 400 nM 
SC1 and 50 μM biliverdin, respectively, to compare 
observed brightness under identical conditions 
and display settings. Images are representative 
samples of data analyzed in B. (B) Box plot of fluo-
romodule/eGFP signal intensity ratios measured 
from protein coexpressed with eGFP in HEK293 
cells as fusion proteins or separate polypeptides 
(P2A). Whiskers indicate maximum and minimum 
values; for boxes, top, line, and bottom indicate 
first, second, and third quartiles, respectively. 
Differences between mean ratios were analyzed 
by 1-way ANOVA: F(3,614) = 5332.14, P < 0.001. A 
Games-Howell post-hoc test shows differences 
between paired group means as denoted by lower-
case letters: a (IFP1.4-eGFP fusion versus separate 
IFP1.4/eGFP peptides, P = 0.650); other pairs 
(ab, ac, bc) describe different means with high 
confidence, P < 0.001. Number of measurements 
(n) per group (IFP1.4/eGFP: 159, IFP1.4-eGFP: 180, 
Mars1Cy/eGFP: 102, Mars1Cy-eGFP: 177) indicate 
the number of unique cells measured. (C) Mars1Cy 
anchored to the plasma membrane by a CD80 
transmembrane domain (TMD) can be labeled with 
membrane-impermeant SCi1. (D) Signal peptide–
prefixed (COXIV) Mars1Cy-eGFP is directed to the 
mitochondria and becomes labeled upon addition 
of the membrane-permeant fluorogen SC1. (E–H) 
Mars1- and Mars1Cy-based fluoromodules can be 
used to tag proteins such as β-actin, vimentin, his-
tone H1.1, and IGF1R in living cells. Images in C–H 
represent at least 10 fields of view per transgene-
hosting cell population. Scale bars: 16 μm.
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The fluorescence excitation spectra of Mars1 and Mars1Cy-
based fluoromodules are broad and often, to our benefit during 
this study, allow excitation from a variety of readily available light 
sources, including 633 and 640 nm diode lasers in addition to the 
670 nm excitation line of the FMT2500LX small animal imaging 
instrument used here for mouse studies. We were unable to excite 
these fluoromodules near their optimal absorbance wavelength 
for our imaging experiments. However, use of commercially avail-
able 690 and 705 nm lasers, which further bypass tissue absorp-
tion and autofluorescence while offering more efficient excitation 
of these fluoromodules, may yield different results, particularly 
for animal imaging applications.
We demonstrated the feasibility of imaging fluoromodules in 
vivo using nude mice and a commercially available small animal 
imager. Fluorescence could be detected from 300 FAP-express-
ing cells implanted underneath the skin. The observed signal is 
at least comparable to an equivalent number of cells that express 
iRFP713, a fluorescent reporter (40, 41), though we did not correct 
for differences in protein expression between the cell strains used. 
We observed during work with cultured cell strains that Mars1Cy 
expression under a CMV promoter could remain stable for weeks 
in the presence of SC1 and in the absence of chemical selection 
agents. Mars1Cy was therefore employed to generate FAP-bearing 
tumors in mice, which were used to assess systemic fluorogen 
delivery. Our data show that both membrane-permeant and mem-
brane-impermeant fluorogens can label FAP-bearing tumors in 
the i.p. cavity upon administration by i.p. and i.v. injection routes 
and that these labeled tumors can be noninvasively visualized. 
SCi1 more robustly labels tumors compared with SC1 at lower 
doses. A number of factors might contribute to this behavior; the 
membrane-permeant fluorogen could be sequestered inside cells 
proximal to the injection site, become bound by serum proteins, or 
undergo rapid clearance.
Mars1:SC1 and the other fluoromodules presented here differ 
in several ways from existing optical reporter/probe systems that 
feature similar reporter-dependent signal activation — a property 
shared by luciferin/luciferase and that is available to the SNAP-
tag approach. The former system is based upon luminescence at 
shorter wavelengths, rather than fluorescence, and light output 
is coupled to oxidation of a substrate rather than excitation and 
emission cycles of a fluorophore. Most fluorogenic SNAP-tag sub-
strates absorb and fluoresce at shorter wavelengths than the fluo-
Figure 3. Mars1Cy-tagged AVPR2 is responsive to desmopressin-stimulated (DDAVP) endocytosis and demonstrates the feasibility of 2-channel separa-
tion of external and internal protein pools using impermeant and membrane-permeant fluorogens that emit in the far-red. (A) HEK293 cells expressing 
Mars1Cy-AVPR2 were incubated at 37°C with the indicated membrane-impermeant fluorogens for 5 minutes prior to stimulation with DDAVP. Images were 
acquired immediately upon agonist application and at 20 minutes after addition. (B) Sequential addition of impermeant fluorogen (either SCi1 or MG-2p, 10 
minutes) followed by permeant fluorogen MG-ester (MGE) or SC1, respectively, for 30 minutes. Each panel is representative of 3 replicates. Scale bars: 16 μm. 
Magnification is constant across all time points.
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romodules discussed here upon activation and consequently may 
experience greater interference from autofluorescence (14–16). 
Relative to existing fluorogenic SNAP-tag substrates, SC1 and SCi1 
exhibit faster signal activation and much greater fluorescence 
enhancements upon binding, though the FAP-fluorogen activa-
tion rates observed here are slower than the exceptional binding 
rates of nonfluorogenic tetramethylrhodamine (TMR) substrates 
with HaloTag variants (42).
In contrast to fluorescent gene reporters, imaging of fluoro-
modules requires addition of an extrinsic reagent — the fluorogen; 
however, systemic delivery via the 2 routes demonstrated here 
makes application of this tool no more laborious than use of other 
reporter/probe systems. One advantage of using a synthetic probe is 
the ability to use different probes with a single reporter. We demon-
strate with SCi1 that membrane permeability is a parameter that can 
be rationally engineered to allow selective probing of extracellular 
Figure 4. Application and quantitation of fluorescence from fluoromodules in living mice. (A) Example of a nude mouse implanted with 300 cells of 
iRFP713-expressing HCT116 cells in the left flank and an equal number of Mars1Cy-expressing cells, prelabeled with SC1, in the right flank. Image is repre-
sentative of data quantified in B. The fluoromodule-hosting cells used here express less protein than the cells hosting iRFP713 (Supplemental Figure 5). 
(B) Fluorescence measured from mice injected and imaged as described in A, using different numbers of cells. Points denote means; bars indicate SEM 
(n = 3: 1 × 105 Mars1Cy-expressing cells, n = 4: others, total animals treated and imaged: 16). Analysis of the same data in terms of relative fluoromodule 
signal yields similar results (Supplemental Figure 6). (C) Fluorescence image of a tumor section (3.2 by 1.7 mm) composed of HCT116 cells that express 
Mars1Cy on the cell surface, labeled by SC1 given i.p. Scale bar: 16 μm. Field is near the center of the section. (D and E) s.c. FAP-bearing tumors that 
express Mars1Cy on the cell surface were labeled by SC1 (400 nM final) administered i.p. and i.v. (tail vein), respectively. (F and G) s.c. tumors as in D and 
E were labeled with SCi1 (400 nM final), injected i.p. or i.v., respectively. (H) i.p. injection of SC1 produces no significant background signal when FAP-
bearing cells are not present. (I and J) Mars1Cy-bearing tumors can be imaged in the i.p. cavity of mice after delivery of SC1 or SCi1, respectively, via  
i.p. injection. Data presented in C–J represent results obtained from 3 samples/animals. Scales in mouse images are given in millimeters. 
The Journal of Clinical Investigation T e c h n i c a l  a d v a n c e
3 9 2 2 jci.org   Volume 125   Number 10   October 2015
uct was subjected to an additional round of random mutagenesis. 
Amplicons were recombined into pPNL6, and the resulting library 
was screened by flow cytometry for activation of SC1 via 633 nm laser 
excitation, with fluorescence detected through a 755/75 nm band-pass 
filter. The brightest 0.5% of activators in the presence of 50 nM SC1 
was enriched over 4 rounds of cell sorting prior to cloning. Cloned 
cells were induced and screened for fluorescence activation of SC1 in 
96-well plates using a Tecan Safire 2. Subsequent sequencing of bright 
clones identified a mutant bearing Y96H mutations in both N- and 
C-terminal chains. This clone was later found to exhibit higher activ-
ity when expressed in mammalian cell cytosol.
S. cerevisiae expression. Mars1 and Mars1Cy genes were cloned 
into pPNL9 to incorporate a C-terminal hexahistidine tag for immobi-
lized metal ion affinity chromatography. The resulting plasmids were 
hosted and expressed in yeast strain YVH10 (45). Protein expression 
and purification protocols followed those previously described (20); 
however, buffer (Wash Buffer G) was composed of 50 mM Tris, pH 7.4, 
500 mM NaCl, 30 mM imidazole, pH 8.0, and 0.015% Triton X-100. 
Elution buffer was identical, with the exception of 250 mM imidazole.
E. coli expression. Expression and purification were conducted 
in the Rosetta-gami 2 strain of E. coli. FAP genes were cloned into a 
modified pET21a vector (a gift from Josef Franke, Carnegie Mellon 
University) that encodes an N-terminal decahistidine tag, followed by 
GST and an HRV3C protease cleavage site. Following IPTG induction 
at 20°C, cells were washed in 25 mM Tris, pH 8.0, with 150 mM NaCl. 
Washed cells were pelleted and frozen (–80°C). Cells were thawed in 
Wash Buffer G and lysed by sonication in the presence of DNase, lyso-
zyme, and PMSF. Lysate was clarified by centrifugation (4°C, 22,789 
g, 45 minutes) and transferred to NiNTA agarose (QIAGEN) for 1 to 
4 hours of incubation at 4°C. Beads were transferred to a column and 
washed prior to addition of His6-tagged HRV3C protease. Following 
overnight incubation, fresh NiNTA agarose was added, and liberated 
protein was washed from the column following 1 hour of incubation.
Absorbance spectroscopy. Data were acquired using a PerkinElmer 
Lambda 45 UV/Vis spectrophotomer at room temperature, set to a 
spectral width of 2.0 nm. All sample path lengths were 1.0 cm.
Molar extinction coefficient measurements. HPLC-purified SC1 was 
dissolved in HPLC-grade methanol and transferred into preweighed 
vessels. The fluorogen samples were dried in a SpeedVac (AES-1000, 
Savant) at 43°C immediately prior to weighing. Known amounts were 
dissolved in methanol supplemented with 5.0% acetic acid, and a 
dilution series was generated from these master stocks. Absorbance 
spectra were obtained for each dilution series element (5 per dilution), 
and the molar extinction coefficient at λmax was determined by linear 
regression on the absorbance versus concentration as calculated from 
the measured mass. Measurement of the SCi1 extinction coefficient 
was impeded by its indeterminate assortment of counter ions. A proxy 
fluorogen, SKC-672, featuring a carboxylic acid in place of the sulfo-
nate moiety, was instead used to determine the extinction coefficient 
of the SCi1 chromophore. Dried SKC-672 (55.5 mg) was transferred 
to a 500 ml volumetric flask and dissolved in methanol to generate a 
master stock of fluorogen. The master stock was used to generate a 
dilution series in methanol supplemented with 5.0% acetic acid. Mea-
surement and analysis proceeded as described for SC1.
Extinction coefficients of Mars1 and Mars1Cy fluoromodules. Master 
stocks used for free fluorogen extinction coefficient measurements 
were diluted to known concentrations (between 500 nM and 1.0 μM 
or whole-cell protein populations. We further used the ability of 
Mars1Cy to bind and activate fluorescence from MG-2p, MG-ester, 
SC1, and SCi1 to show that extracellular and intracellular pools of a 
FAP-tagged receptor can be labeled with different-colored probes — 
a capability that may be useful for protein trafficking or pulse-chase 
studies. This particular labeling scheme could be difficult to apply 
in vivo, since MG-2p and MG-ester are less spectrally compatible 
with tissue. However, it illustrates one manner in which multiple 
probes can be employed. We are excited to further explore whether 
other chemical groups or compounds could be coupled in place of 
the short linker and sulfonate on SCi1 without ablating binding or 
fluorescence activation. Neither far-red fluorogen was designed 
with consideration of biodistribution in animals, and we have not 
yet explored parameters such as the rate of clearance in mice. We 
expect that the in vivo labeling effectiveness of these fluorogens 
could be improved by attaching chemical substituents known to 
alter small molecule retention within living animals (43). Coupling 
to polyethylene glycol, for example, may increase the solubility and 
circulation time of the molecule and consequently decrease the 
quantity of fluorogen required for effective labeling. Additional flu-
orogen modification strategies to increase probe brightness or allow 
the probe to report pH have been demonstrated in vitro and on cul-
tured cells (23, 24) and may be adapted to SC1-based fluorogens to 
further extend their usefulness.
Methods
Cell lines and strains. HEK293, HeLa, and HCT116 cell lines used in 
this study originated from ATCC. The Phoenix-GP retroviral pack-
aging strain was provided by Margaret Fuhrman (Carnegie Mellon 
University). The 293FT strain used for lentiviral packaging was pur-
chased from Invitrogen. E. coli strain NEB10β was obtained from New 
England Biolabs; Rosetta-gami 2 was from Novagen. Yeast plasmids 
(pPNL6, pPNL9) and S. cerevisiae strain YVH10 are components of 
an scFv library obtained from Pacific Northwest National Labora-
tory (http://www.sysbio.org/dataresources/index.stm). JAR200 cells, 
provided by Andrew Rakestraw (Massachusetts Institute of Technol-
ogy, Cambridge, Massachusetts, USA), were obtained via Christopher 
Szent-Gyorgyi (Carnegie Mellon University).
Mars1. The light chain of HL9-MG was converted into a tandem 
dimer by attachment of a glycine-serine linker followed by a codon-
scrambled L9 gene via PCR. The L9 tandem dimer gene was subjected 
to PCR-mediated random mutagenesis and cloned into pPNL9 to gen-
erate an expression library suitable for high-speed cell sorting (44). 
Library elements were induced in shaking culture flasks for 5 days at 
20°C in secretion media (20) prior to being screened for fluorescence 
activation of MG-ester on a FACSVantage SE flow cytometer with 
FACSDiva Option (BD) by 633 nm laser excitation, viewed through 
a 685/70 nm band-pass filter. The brightest 0.3% of activators in the 
presence of 50 nM MG-ester were enriched over 4 rounds of sorting. 
Single cells from round 5 were picked, grown, and induced in the same 
manner as used to screen the library described above, and their induc-
tion media was assessed for FAP activity by assessing MG-ester fluo-
rescence activation using a Tecan Safire 2 plate reader. A clone with 
particularly high yields hosting a V70A mutation in the N-terminal 
light chain was designated Mars1.
Mars1Cy. The V70A mutation was propagated to the C-terminal 
light chain by PCR-based site-directed mutagenesis, and the prod-
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FAPs omitted exhibited negligible fluorescence under identical 
measurement conditions.
Cloning and use of FAP-expressing vectors. Restriction enzymes 
were purchased from New England Biolabs Inc. as were polymerase 
(Q5 DNA polymerase) and ligase (Quick Ligation Kit). Primers were 
purchased from Life Technologies, Bioneer Inc., and Integrated DNA 
Technologies. Transformations and DNA propagation steps were con-
ducted in the commercial E. coli strain NEB10β.
Plasma membrane display of Mars1 and Mars1Cy. An ORF bearing 
an Igκ signal sequence and HA epitope, followed by a murine CD80 
transmembrane anchor (49) flanked by 5′ XbaI and XmnI, and 3′ 
SpeI and XmaI cloning sites, was inserted into pEGFP-C2 (Clontech) 
between NheI and XmaI sites. External display plasmids pOIMars1N 
and pOIMars1CyN were generated by cloning the respective FAP 
genes between the XbaI and XmnI sites. Transfection of HEK293 
cells with these constructs was accomplished via use of FuGENE 6 
(Roche Applied Science) in accordance with manufacturer-supplied 
protocols. Stable cells were selected by application of G418 for 1 
week. Clones were isolated by flow cytometry and expanded. Postex-
pansion expression stability was reverified by flow cytometry. Unless 
noted, other mammalian expression plasmids were used to generate 
stable strains in a similar fashion. The authors were unable to con-
firm expression by fluorescence signal from cells transfected with 
analogous iRFP713 constructs.
Cytoplasmic expression of Mars1Cy-eGFP fusions. Overlapping PCR 
primers were used to assemble and amplify an ORF encoding Mars1Cy 
tethered to eGFP by a peptide linker (GGRASGGGASGGGSGGSG) 
flanked by NheI and XmaI sites. Amplicons were digested and ligated 
into like-digested plasmid backbone prepared from pOIMars1N to 
generate pMars1Cy-eGFP.
Cytoplasmic expression of eGFP and Mars1Cy from a bicistronic tran-
script. Plasmid pP2AeGFPMars1Cy was constructed by fusing a nucle-
ic acid sequence encoding a P2A site between eGFP and Mars1Cy 
fragments via overlapping primer PCR. The resulting amplicon was 
inserted in place of Mars1Cy-eGFP in the plasmid pMars1Cy-eGFP.
Mitochondrial expression of Mars1Cy-eGFP. Overlapping primers 
were used to fuse a mitochondrial localization signal that consists of 
the N-terminal 23 amino acids of cytochrome c oxidase subunit IV (H. 
sapiens) to the N terminus of Mars1Cy-eGFP via PCR. The amplicon 
was used to replace Mars1Cy-eGFP in pMars1Cy-eGFP, yielding pMT-
Mars1Cy-eGFP.
Retrovirus for stable expression of Mars1 and Mars1Cy fusion pro-
teins. A pBABE retroviral vector was modified to host a 1.5-kb frag-
ment of A2UCOE (50), followed immediately by a CMV promoter and 
an ORF, between existing BamHI and SalI restriction sites. The ORF 
of this derivative vector, designated pUB, was flanked by AgeI and 
SalI sites, between which various FAP fusion proteins were cloned. A 
modified plasmid containing a 3′ SbfI cloning site was also generated. 
Retroviral packaging was accomplished using the Phoenix-GP cell line 
(51) by cotransfection of pMD2.g with FAP-hosting pUB vectors. Viral 
supernatant, supplemented with polybrene (0.6 μg/ml), was used to 
transduce HeLa cells in order to produce strains used for imaging of 
FAP-tagged proteins.
Lentiviral vectors for stable transduction of tumorigenic cell lines. 
A parent vector, pLenti-CaMKIIa-hChR2(E123T-H134R)-EYFP (52) 
(a gift from the Deisseroth lab, Stanford University, Stanford, Cali-
fornia, USA) was modified by substitution of all content between PacI 
in order to remain well above the estimated fluoromodule dissocia-
tion constant) in PBS, pH 7.4, supplemented with 1.0 mM EDTA. An 
excess of purified FAP was added and mixed. Absorbance scans were 
collected until absorbance at λmax stabilized.
Quantum yield of Mars1 and Mars1Cy fluoromodules. Relative quan-
tum yield measurements were conducted using Cy5.18 (PBS, pH 7.4) 
and oxazine-1 (ethanol) by the gradient method (46–48). For each rep-
licate, at least 5 fluoromodule samples were constituted using various 
fluorogen concentrations at least 20-fold greater than the dissociation 
constant in the presence of excess purified protein. The solutions were 
allowed to complex at 4°C for at least 1 hour prior to reequilibration 
and measurement at room temperature. Fluorescence spectra were 
obtained using a Quantamaster fluorometer (Photon Technology 
International) equipped with dual excitation and emission monochro-
mators set to 2.00 mm (approximately 5.0 nm spectral windows). 
Emission spectra were integrated using Spekwin32, version 1.71.6.1 
(http://www.effemm2.de/spekwin/), and relative quantum yield was 
determined via linear fit to area versus absorbance plots.
Fluoromodule binding properties. Fluoromodule dissociation con-
stants KD were measured using a ligand depletion assay. 5.0 nM FAP 
was titrated against each fluorogen at concentrations from 10 pM to 
1.0 μM. Each complex was allowed to equilibrate at 4°C, and fluores-
cence of these complexes was measured using a fluorescence plate 
reader (Infinite M1000, Tecan) at the emission maximum. The curve 
obtained using this method was fit to a ligand depletion model to yield 
the KD. For on-rate measurements, FAP solutions were prepared in 
PBS, pH 7.4, supplemented with 0.01% Pluronic F127 at a concentra-
tion equal to the KD of the fluoromodule. These solutions were taken 
in a 4 ml quartz cuvette, and fluorescence was measured using a fluo-
rometer (Photon Technology International). Time dependence of 
fluorescence was measured at the respective emission peaks after the 
addition of the fluorogen. For each FAP, fluorogen was used at concen-
trations of 5, 10, 50, and 100 equivalents of the experimentally deter-
mined KD. On-rate curves were fit using an exponential growth model. 
The association rates (kon*) determined from these curves were plotted 
against the fluorogen concentration and the slope of the curve yielded 
the on-rate for the complex.
Fluorescence enhancement measurement. Fluorogens SC1 and SCi1 
were diluted to 500 nM in PBS, pH 7.4, supplemented with 1.0 mM 
EDTA. Purified Mars1Cy or Mars1 was added to achieve a 10-fold 
excess of protein to fluorogen. Control solutions were prepared in 
the same manner, but with no FAP. Solutions were mixed and dis-
tributed in a black 96-well flat-bottom plate (Greiner) with 160 μl of 
each solution per well, 12 replicates per sample type. The samples 
were allowed to equilibrate at room temperature for 1 hour. Mea-
surements were conducted with a Tecan Safire 2 plate reader using 
instrument-optimized gain in extended dynamic range mode, 40 μs 
integration time, exciting at 700 nm and collecting at 730 nm, and 
with bandwidths set to 8 nm.
Characterization of fluoromodule pH sensitivity. Fluoromodules 
were prepared as 50-fold stocks in 10 mM Tris, pH 7.4, with 300 mM 
NaCl prior to dilution into each buffered pH condition, yielding 500 
nM fluoromodule (fluorogen-limited). Five replicate wells were pre-
pared for each pH condition. Measurements were obtained after 60 
minutes of room temperature incubation and again after 30 hours 
using a Tecan Safire 2 plate reader, exciting each sample at 695 nm 
and recording fluorescence at 730 nm. A parallel set of samples with 
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replicate. Scatter was used to designate cell-sized and bead-sized 
populations in FlowJo X (LLC) for which median fluorescence values 
were calculated in eGFP (488:530/30) and fluoromodule (633:755/75) 
channels. Median intensity values were converted to molecules of 
equivalent soluble fluorophore (MESF) using QuickCal 2.3 (Bangs 
Laboratories Inc.). Data are presented as the normalized mean MESF 
for 3 replicates per condition with associated SD.
Comparison of protein brightness in living cells. Cells were plated 
in imaging dishes (MatTek Corp.) 24 hours prior to each experiment. 
Cells expressing IFP1.4 were cultured in media supplemented with 
50 μM biliverdin-IX for at least 48 hours prior to imaging, while cells 
expressing Mars1Cy were labeled 4 to 24 hours prior to imaging by add-
ing fluorogen directly to growth media. Imaging was conducted on an 
Andor Revolution XD spinning disk confocal microscope using a ×60 
1.49 NA oil immersion objective. Signal from eGFP was acquired dur-
ing excitation at 488 nm using a 525/50 nm band-pass filter (Semrock 
FF03-525/50-25), while IFP1.4 and Mars1Cy were excited by laser at 
640 nm and emission collected through a 731/137 nm band-pass filter 
(Semrock FF01-731/137-25). Images were processed in ImageJ (53): 
mean pixel intensities from eGFP and fluoromodule emission chan-
nels were measured from ROIs drawn around transfected cells and 
a blank area in each frame. Blank ROI values were subtracted from 
cell ROI values measured from the same frame to generate corrected 
means for eGFP and fluoromodule channels from which fluoromod-
ule/eGFP signal ratios were calculated for every cell. Box plots were 
generated using RStudio. Ratios were analyzed by 1-way ANOVA fol-
lowed by a Games-Howell post-hoc test in SPSS v23 (IBM).
Labeling of Mars1Cy-AVPR2. HEK293 cells expressing Mars1Cy-
AVPR2 were labeled with impermeant fluorogen SCi1 or MG-2p 
(200 nM, 5 minutes at 37°C) and stimulated with desmopressin 
(Sigma-Aldrich, 10 μM). Samples were sequentially excited with 488 
nm and 640 nm lasers, and emission was collected through 685/70 
and 794/160 nm band-pass filters for each respective channel. For 
dual-color labeling with spectrally separated external and internal 
far-red labels, SCi1 was applied at 200 nM for 10 minutes, followed by 
addition of MG-ester at 100 nM for 30 minutes prior to imaging. To 
achieve the inverse labeling scheme, MG-2p was applied at 200 nM 
for 10 minutes, followed by addition of SC1 at 200 nM for 30 min-
utes to label the extracellular receptor pool far red and the intracel-
lular pool farther red.
Cell culture in the presence of SC1. A stable HEK293 clone 
expressing cytosolic Mars1Cy-eGFP was cultured in DMEM and 
10% FBS supplemented with 200 nM SC1 from a 1,000× stock in 
DMSO. Cells were split 1:10 every 48 to 72 hours, and percentages 
of positive cells were monitored by flow cytometry every 4 to 7 days 
from day 6 to day 52.
Imaging Mars1-expressing cells with nonbinding dyes. HEK293 cells 
stably expressing Mars1 on the plasma membrane were plated onto 
glass bottom dishes 24 hours prior to imaging. A dye (TRITC, Lissa-
mine Green B, oxazine 1, methylene blue, Cy5.18, or Cy7) was added 
to a final concentration of 500 nM in each dish. Cells were incubated 
under normal growth conditions (37°C, 5% CO2) for 60 minutes prior 
to imaging using an Andor Revolution XD spinning disk confocal 
microscope equipped with a ×60 1.49 NA oil immersion objective. 
Samples were imaged under 4 channels (bright field, 560:607/36, 
640:685/70, 640:794/160). Each dish of cells was supplemented 
with SCi1 to a final concentration of 500 nM and returned to a tissue 
and EcoRI sites with an insert encoding the promoter and ORF from 
pOIMars1N fused upstream of an IRES and puromycin resistance 
gene. The Mars1Cy-eGFP fusion protein ORF was amplified from 
pMars1Cy-eGFP using primers that maintained the 5′ AgeI restriction 
site and appended a 3′ BsrGI site. The digested amplicon was cloned 
into like-digested lentiviral vector to generate pLenCMV-Mars1Cy-
eGFPiPac. The analogous vector, pLenCMV-iRFP713eGFPiPac, was 
produced by amplifying iRFP713 with primers that introduced flank-
ing AgeI and AscI restriction sites, followed by standard digestion/
ligation cloning. The plasma membrane–targeted Mars1Cy ORF from 
pOIMars1CyN was amplified with primers that preserved the 5′ AgeI 
site and appended a sequence for fusion with eGFP at 7 amino acids 
after the predicted end of the membrane-spanning segment. This 
PCR product was further amplified in the presence of eGFP template 
DNA and primers that yielded 5′ AgeI and 3′ BsrGI restriction sites 
that flanked the assembled product. Cloning into the pLenCMV-
Mars1Cy-eGFPiPac vector backbone at these sites afforded pLenC-
MV-PMMars1Cy-eGFPiPac for plasma membrane–directed expres-
sion of a Mars1Cy-eGFP fusion protein. Viral particles were packaged 
using the ViraPower Lentiviral Packaging Mix (Invitrogen K4975) 
and 293FT cells in accordance with product-supplied protocols. 
Transduced cells were sorted for FAP activity via fluorogen activa-
tion or iRFP713 activity by flow cytometry. Clones from sorting were 
maintained in the presence of puromycin (5 μg/ml).
Igκ-Mars1Cy was amplified with primers that preserved the 
5′ AgeI site and appended a sequence that encodes a 16-residue 
C-terminal linker (GTAAAGAGAAGGAAAG). This PCR amplicon 
was further amplified using the original forward primer and a reverse 
primer that appended a sequence encoding the full first exon of 
H. sapiens AVPR2 and the first five 5′ nucleotides of exon 2. Separate-
ly, human genomic DNA was amplified using primers that annealed 
to the 5′ terminus of AVPR2 exon 2 and the 3′ terminus of exon 3, 
including the native stop codon. These primers flanked the interven-
ing DNA with a 5′ extension that complements the 3′ terminus of the 
extended Mars1Cy amplicon and a 3′ extension encoding a BsrGI 
restriction site. The 2 resulting fragments were amplified together 
using their respective 5′ and 3′ terminal primers to produce Igκ-
Mars1Cy-AVPR2 (including introns 2-3), which was cloned into a vec-
tor backbone of AgeI- and BsrGI-digested pLenCMV-PMMars1Cy-
eGFPiPac to produce pLenCMV-PMMars1CyAVPR2.
Analysis of fluorogen membrane permeance. HEK293 cells express-
ing Mars1Cy or untransfected controls were grown in DMEM supple-
mented with 10% FBS and 500 μg/ml G-418 (736 μg/mg potency). 
Cells were expanded onto three 100-mm dishes and grown to 50% 
confluence prior to collection by application of 1.0 ml 0.25% trypsin-
EDTA (Gibco; Life Technologies). Detached cells were washed and 
resuspended with fresh DMEM to yield 1.0 ml per condition. Analy-
sis was performed on the previously described BD instrument using 
488:530/30, 488:610/20, 633:685/70, and 633:755/75 channels. Bas-
al fluorescence was recorded for transfected and untransfected cells 
at room temperature, while 37°C and on-ice samples were allowed 
to equilibrate. Stock fluorogen in methanol or DMSO was diluted 
10-fold in DMEM prior to addition to cell suspensions. Sixty-second 
acquisitions (recording approximately 10,000–40,000 cells) were 
performed immediately upon addition of fluorogen to 200 nM and 
at intervals afterwards. Fluorescence calibration beads (Bangs Labo-
ratories Inc., product 822A, lot 10376) were measured during each 
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SKC-672. 450 mg of SKC-660 was suspended in 50 ml THF. 15% 
LiOH aqueous solution was added and stirred at room temperature 
for 24 hours. The organic layer was separated. The aqueous layer was 
extracted with 3 × 50 ml CHCl3 and combined with the organic layer. 
The organic fraction was dried over anhydrous MgSO4 and concen-
trated to 20 ml. 200 μl of 60% HClO4 was added slowly and stirred at 
room temperature for 1 hour. Upon concentration, the blue residue was 
purified by flash chromatography on SiO2 using 10% methanol in chlo-
roform as eluent, which resulted in 200 mg (47% yield) of pure product 
(Supplemental Figure 10). The product had a chemical composition of 
C31H38N3O2
+ with a MW of 484.65 g/mol. The 1H-NMR (CD3OD) spec-
tra were as follows: δ 6.65–7.88 (m, 14H); 3.33 (m, 9H); 2.99 (m, 2H); 
2.91 (m, 3H); 2.31 (m, 2H); 1.66 (m, 4H), and ESI-MS (+) of 484.3.
SKC-722. SKC-672 (162 mg) was dissolved in 3 ml anhydrous 
DMF. 160 mg of TSTU and 25 μl of diisopropylethylamine were added. 
The mixture was stirred (room temperature, 3 hours). After concentra-
tion under vacuum, the residue was precipitated by diethyl ether and 
dried, yielding 173 mg of active ester SKC-722 (Supplemental Figure 
10). The product had a chemical composition of C35H41N4O4
+ with a 
MW of 581.72 g/mol (89% yield). The 1H-NMR (CD3OD) spectra were 
as follows: δ 6.53–7.82 (m, 14H); 3.21–3.38 (m, 12H); 3.12 (m, 4H); 2.89 
(m, 2H); 2.31 (m, 2H); 1.42 (m, 4H), and ESI-MS (+) of 581.3.
SCi1. SKC-722 (58 mg, 1 mmol) and DL-homocysteic acid (23 mg, 
1.25 mmol) were dissolved in 2 ml anhydrous DMF. DIPEA (20 μl) 
was added, and the reaction was stirred at room temperature for 24 
hours. The product was concentrated, and the residue was purified by 
flash chromatography on SiO2 using 20% methanol in chloroform as 
eluent, which provided 51 mg of pure product (Supplemental Figure 
10). The product had a chemical composition of C35H45N4O6S
+ with a 
MW of 649.81 g/mol (78% yield). The 1H-NMR (CD3OD) spectra were 
as follows: δ 6.78–7.99 (m, 14H); 2.72-3.33 (m, 14H); 3.39 (m, 4H); 2.35 
(m, 2H); 1.31 (m, 4H), and ESI-MS (+) of 649.
Animal studies. Athymic nude mice (Taconic Biosciences Inc., 
catalog NCRNU-F sp/sp), aged 6 to 8 weeks, were used for all in vivo 
imaging experiments and were maintained on alfalfa and soybean-free 
feed (Harlan Teklad, catalog 2916). Labeling of Mars1Cy-expressing 
HCT116 cells for comparison with iRFP713 was conducted ex vivo by 
incubation of cells with fluorogen (SC1) at 400 nM prior to collection 
and injection. The s.c. implantation of different numbers of cells was 
achieved using a total volume of 200 μl as a 1:1 suspension of cells and 
PBS in Matrigel (Corning Life Sciences). Four mice contributed data per 
each number of injected cells, with the exception of 1 × 105/Mars1Cy, 
for which 3 mice were analyzed. For other studies, tumorigenic cells 
suspended in PBS were implanted either s.c. or into the i.p. cavity as 
described in the figure legends, as are the cell lines used. For systemic 
FAP labeling, fluorogen was administered to approximately 400 nM 
via i.v. or i.p. injection. Imaging of live animals was conducted using 
an FMT2500LX (PerkinElmer), applying the built-in 680 fluorescence 
channel (670 nm excitation, 690–740 nm emission collection) in quan-
titative tomography mode, with mice held under 2% isoflurane. Data 
were acquired from 20–24 illumination points over the course of 3 to 5 
minutes per animal. Quantitation was conducted with the instrument 
software suite (TrueQuant version 3.1, PerkinElmer) after calibra-
tion with purified protein solutions of known concentration. Fluores-
cence imaging of tumor sections was conducted with the previously 
described Andor microscope system, using 640 nm excitation coupled 
with a 794/160 emission filter through a ×60 1.49 NA oil immersion 




benzaldehyde (149 mg, 1 mmol) and 4,4′–vinylidene bis (N,N- dimeth-
ylaniline) (300 mg, 1.12 mmol) were dissolved in 5 ml acetic anhydride, 
and 200 μl of 60% perchloric acid was added slowly. The solution was 
refluxed for 3 hours with stirring, then cooled to room temperature. 
Precipitated by diethyl ether, the blue residue was purified by silica gel 
column chromatography using 10% methanol in chloroform, yielding 
242 mg deep blue solid as product (Supplemental Figure 8). The product 
had a chemical composition of C27H32N3
+ with a MW of 398.56 g/mol 
(61% yield). The 1H-NMR (CD3OD) spectra were as follows: δ 7.72–7.85 
(m, 2H); 7.53 (d, 2H); 7.45 (d, 1H); 7.12 (d, 1H); 6.52–6.98 (m, 8H); 3.24 
(d, 12H); 2.9 (m., 6H), and electrospray ionization mass spectrometry 
(ESI-MS) (+) of 398.3.
SKC-657: [Ethyl 5-(methyl(phenyl)amino)pentanoate]. 5.52 ml 
(48 mmol) of N-methyl aniline, 8 ml bromovalerate (50.2 mmol), and 
2,6- lutidine (5.82 ml, 50.2 mmol) were taken in 100 ml acetonitrile 
and refluxed for 24 hours while stirring. Acetonitrile was removed 
under vacuum, and residues were dissolved in ether and water. The 
organic phase was collected and washed with water. After drying over 
magnesium sulfate and filtering, the solvent was removed, leaving a 
brown liquid. The residue was purified by flash chromatography on 
SiO2 using a 10% ethyl acetate in hexane as eluent, giving 10.1 g light 
yellow oil as product (Supplemental Figure 9). The product had a 
chemical composition of C14H21NO2 with a MW of 235.32 g/mol (90% 
yield). The 1H-NMR (CDCl3) spectra were as follows: δ 7.25 (m, 2H); 
6.72 (m, 3H); 4.15 (m, 2H); 3.35 (m, 2H); 2.94 (s, 3H); 2.35 (m, 2H); 
1.67 (m, 4H); 1.27 (m, 3H), and ESI-MS (+) of 235.62.
SKC-659: [Ethyl 5-((4-formylphenyl)(methyl)amino)pentanoate]. 
2.94 g (1.25 mmol) of SKC-657 was dissolved in 10 ml dry DMF and 
cooled to –5°C by salt ice bath. 5 ml of POCl3 was added drop wise 
over a period of 1 hour at –5°C, and the reaction mixture was stirred 
at room temperature for 20 hours. The temperature was raised to 
90°C for 2.5 hours. This was cooled to room temperature after which 
we poured in 200 g of ice water, neutralized by solid K2CO3. The 
mass was extracted 3 times with 75 ml CHCl3. The combined organ-
ic layer was washed with 2 × 100 ml water and dried over anhydrous 
MgSO4. Concentration under vacuum resulted in 2.2 g light brown 
oil (Supplemental Figure 9). The product had a chemical compo-
sition of C15H21NO3 with a MW of 263.33 g/mol (66% yield). The 
1H-NMR (CDCl3) spectra were as follows: δ 9.76 (s, 1H); 7.75 (d, 2H); 
6.80 (d, 2H); 4.14 (m, 2H); 3.44 (m, 2H); 3.07 (s, 3H); 2.35 (m, 2H); 
1.68 (m, 4H); 1.27 (m, 3H), and ESI-MS (+) of 263.23.
SKC-660. 1.3 g (5 mmol) of SKC-659 and 1.6 g (6 mmol) of 4, 
4′–vinylidene bis (N,N-dimethylaniline) were suspended in 15 ml 
acetic anhydride, and 400 μl of 60% perchloric acid was added 
slowly. The blue reaction mixture was stirred at room temperature 
for 20 hours and concentrated; the residue was purified by flash 
chromatography on SiO2 using a 5% methanol in chloroform as elu-
ent, resulting in 600 mg of deep blue solid (Supplemental Figure 9). 
The product had a chemical composition of C33H42N3O2
+ with a MW 
of 512.70 g/mol (24% yield). The 1H-NMR (CD3OD) spectra were as 
follows: δ 7.42–7.99 (m, 9H); 6.76–6.97 (m, 5H); 4.15 (m, 2H), 3.61 
(m, 2H); 3.23 (s, 6H); 2.39 (m, 2H); 2.01 (s, 6H); 1.71 (m, 4H); 1.25 
(m, 3H), and ESI-MS (+) of 512.3.
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objective or a ×20 0.75 NA air objective (Figure 4C and Supplemental 
Figure 7, A–C, respectively). Andor IQ software was used to collect fluo-
rescence images as a tiled set of fields with approximately 15% overlap 
between adjacent fields.
Statistics. Statistical tests are described alongside the data to 
which they were applied. P < 0.05 was considered significant.
Study approval. All studies were approved by the IACUC at the 
University of Pittsburgh.
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